Loading...

Talmadge E. King Jr, MD

Title(s)Dean-SOM/VC-Medical Affairs, Dean's Office
SchoolSchool of Medicine
Address513 Parnassus Ave, MSB
San Francisco CA 94117
Phone415-476-2342
vCardDownload vCard
    Other Positions
    Title(s)Dean of the UCSF School of Medicine

    Title(s)Vice Chancellor – Medical Affairs


    Collapse Biography 
    Collapse Education and Training
    University of Colorado Medical CenteFellowship1979Pulmonary/Critical Care
    Emory UniversityResidency1977Internal Medicine
    Harvard UniversityM.D.1974School of Medicine
    University of California, San Francisco, CA2018Diversity, Equity, and Inclusion Champion Training
    Collapse Awards and Honors
    Association of Professors of Medicine (APM)20162016 APM Robert H. Williams, MD, Distinguished Chair of Medicine Award
    Foundation of the American Thoracic Society 2012Breathing for Life Award
    Gustavus Adolphus College2012Sesquicentennial Award
    American Academy of Arts and Sciences2011 Fellow
    American College of Physicians 2010Master
    Gustavus Alumni Association, Gustavus Adolphus College2008Alumni Citation
    American Thoracic Society2007Trudeau Medal
    Institute of Medicine, National Academy of Sciences2004Member
    Public Advisory Roundtable of the American Thoracic Society2003PAR Excellence Award
    Association of American Physicians1998Member
    California Thoracic Society1998Elected honorary member
    Colorado Thoracic Society, American Lung Association of Colorado1998Member. Colorado Pulmonary Hall of Fame
    The Fleischner Society 1997Member
    Western Association of Physicians 1993Member
    American Lung Association of Colorado1992James J. Waring Award For Outstanding Leadership in the Treatment of Lung Disease
    American College of Physicians 1986Fellow
    American College of Chest Physicians1984Fellow
    Alumni Association, Gustavus Adolphus College1980First Decade Award for Early Achievement
    Gustavus Adolphus College1970Guild of St. Ansger Honor Society

    Collapse Overview 
    Collapse Overview
    Dr. Talmadge E. King, Jr. was named dean of the UCSF School of Medicine and vice chancellor for medical affairs in May of 2015. He began his career at UCSF in 1997 as chief of Medical Services at Priscilla Chan and Mark Zuckerberg San Francisco General Hospital and Trauma Center. From 2006 to 2015, he served as chair of the UCSF Department of Medicine, the largest department in the school, with approximately 29 percent of the school's full-time faculty.

    A physician-scientist, King’s research has focused on inflammatory and immunologic lung injury. He is best known for his pioneering work in the management of the interstitial pneumonias, a scarring process that often leads to death. His bibliography comprises more than 300 publications and he has co-edited eight books, including the acclaimed reference book, "Interstitial Lung Disease," now in its fifth edition.

    King graduated from Gustavus Adolphus College and earned his medical degree at Harvard Medical School, followed by a residency at Emory University Affiliated Hospitals in Atlanta, Ga. and a pulmonary fellowship at the University of Colorado Health Sciences Center in Denver.

    He is a member of the Institute of Medicine of the National Academy of Sciences, American Academy of Arts and Sciences, Association of American Physicians, American Clinical and Climatological Association and the Fleischner Society. He is a master of the American College of Physicians and fellow of the American College of Chest Physicians. He won the 2007 Trudeau Medal, the highest honor of the American Thoracic Society.

    Collapse Research 
    Collapse Research Activities and Funding
    Idiopathic Pulmonary Fibrosis Clinical Research Network
    NIH/NHLBI U10HL080685May 1, 2005 - Apr 30, 2012
    Role: Principal Investigator
    IMMUNOLOGIC REGULATION OF PULMONARY FIBROSIS
    NIH P50HL056556Dec 1, 1996 - Jan 31, 2002
    Role: Co-Investigator
    General Clinical Research Center
    NIH M01RR000051Dec 1, 1978 - Mar 31, 2010
    Role: Co-Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials
    Collapse Websites
    Collapse In The News
    Collapse Featured Videos

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. NIH Workshop Report: E-cigarette or Vaping Product Use Associated Lung Injury (EVALI): Developing a Research Agenda. Am J Respir Crit Care Med. 2020 Apr 03. Crotty Alexander LE, Ware LB, Calfee CS, Callahan SJ, Eissenberg T, Farver C, Goniewicz ML, Jaspers I, Kheradmand F, King TE, Meyer NJ, Mikheev V, Shields PG, Shihadeh A, Strongin R, Tarran R. PMID: 32243764.
      View in: PubMed   Mentions: 1     Fields:    
    2. How Small Differences in Assessed Clinical Performance Amplify to Large Differences in Grades and Awards: A Cascade With Serious Consequences for Students Underrepresented in Medicine. Acad Med. 2018 09; 93(9):1286-1292. Teherani A, Hauer KE, Fernandez A, King TE, Lucey C. PMID: 29923892.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    3. Lessons From an Educational Never Event. JAMA Intern Med. 2017 10 01; 177(10):1415-1416. Lucey CR, Navarro R, King TE. PMID: 28846754.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    4. Mortality Risk Prediction in Scleroderma-Related Interstitial Lung Disease: The SADL Model. Chest. 2017 11; 152(5):999-1007. Morisset J, Vittinghoff E, Elicker BM, Hu X, Le S, Ryu JH, Jones KD, Haemel A, Golden JA, Boin F, Ley B, Wolters PJ, King TE, Collard HR, Lee JS. PMID: 28629914.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    5. The performance of the GAP model in patients with rheumatoid arthritis associated interstitial lung disease. Respir Med. 2017 06; 127:51-56. Morisset J, Vittinghoff E, Lee BY, Tonelli R, Hu X, Elicker BM, Ryu JH, Jones KD, Cerri S, Manfredi A, Sebastiani M, Gross AJ, Ley B, Wolters PJ, King TE, Kim DS, Collard HR, Lee JS. PMID: 28502419.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    6. The use of pretest probability increases the value of high-resolution CT in diagnosing usual interstitial pneumonia. Thorax. 2017 May; 72(5):424-429. Brownell R, Moua T, Henry TS, Elicker BM, White D, Vittinghoff E, Jones KD, Urisman A, Aravena C, Johannson KA, Golden JA, King TE, Wolters PJ, Collard HR, Ley B. PMID: 28082530.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    7. Early Experiences After Adopting a Quality Improvement Portfolio Into the Academic Advancement Process. Acad Med. 2017 01; 92(1):78-82. Sehgal NL, Neeman N, King TE. PMID: 27119329.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    8. A diagnostic model for chronic hypersensitivity pneumonitis. Thorax. 2016 10; 71(10):951-4. Johannson KA, Elicker BM, Vittinghoff E, Assayag D, de Boer K, Golden JA, Jones KD, King TE, Koth LL, Lee JS, Ley B, Wolters PJ, Collard HR. PMID: 27245779.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    9. Effect of continued treatment with pirfenidone following clinically meaningful declines in forced vital capacity: analysis of data from three phase 3 trials in patients with idiopathic pulmonary fibrosis. Thorax. 2016 05; 71(5):429-35. Nathan SD, Albera C, Bradford WZ, Costabel U, du Bois RM, Fagan EA, Fishman RS, Glaspole I, Glassberg MK, Glasscock KF, King TE, Lancaster L, Lederer DJ, Lin Z, Pereira CA, Swigris JJ, Valeyre D, Noble PW, Wells AU. PMID: 26968970.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansCTClinical Trials
    10. Safety of pirfenidone in patients with idiopathic pulmonary fibrosis: integrated analysis of cumulative data from 5 clinical trials. BMJ Open Respir Res. 2016; 3(1):e000105. Lancaster L, Albera C, Bradford WZ, Costabel U, du Bois RM, Fagan EA, Fishman RS, Glaspole I, Glassberg MK, King TE, Lederer DJ, Lin Z, Nathan SD, Pereira CA, Swigris JJ, Valeyre D, Noble PW. PMID: 26835133.
      View in: PubMed   Mentions:
    11. Pirfenidone for idiopathic pulmonary fibrosis: analysis of pooled data from three multinational phase 3 trials. Eur Respir J. 2016 Jan; 47(1):243-53. Noble PW, Albera C, Bradford WZ, Costabel U, du Bois RM, Fagan EA, Fishman RS, Glaspole I, Glassberg MK, Lancaster L, Lederer DJ, Leff JA, Nathan SD, Pereira CA, Swigris JJ, Valeyre D, King TE. PMID: 26647432.
      View in: PubMed   Mentions: 41     Fields:    Translation:Humans
    12. American Thoracic Society-European Respiratory Society Classification of the Idiopathic Interstitial Pneumonias: Advances in Knowledge since 2002. Radiographics. 2015 Nov-Dec; 35(7):1849-71. Sverzellati N, Lynch DA, Hansell DM, Johkoh T, King TE, Travis WD. PMID: 26452110.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    13. Survival in interstitial pneumonia with features of autoimmune disease: a comparison of proposed criteria. Respir Med. 2015 Oct; 109(10):1326-31. Assayag D, Kim EJ, Elicker BM, Jones KD, Golden JA, King TE, Koth LL, Shum AK, Wolters PJ, Collard HR, Lee JS. PMID: 26303338.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    14. Sensitivity Analyses of the Change in FVC in a Phase 3 Trial of Pirfenidone for Idiopathic Pulmonary Fibrosis. Chest. 2015 Jul; 148(1):196-201. Lederer DJ, Bradford WZ, Fagan EA, Glaspole I, Glassberg MK, Glasscock KF, Kardatzke D, King TE, Lancaster LH, Nathan SD, Pereira CA, Sahn SA, Swigris JJ, Noble PW. PMID: 25856121.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCTClinical Trials
    15. The effect of bronchodilators on forced vital capacity measurement in patients with idiopathic pulmonary fibrosis. Respir Med. 2015 Aug; 109(8):1058-62. Assayag D, Vittinghoff E, Ryerson CJ, Cocconcelli E, Tonelli R, Hu X, Elicker BM, Golden JA, Jones KD, King TE, Koth LL, Lee JS, Ley B, Shum AK, Wolters PJ, Ryu JH, Collard HR. PMID: 26140806.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    16. CT staging and monitoring of fibrotic interstitial lung diseases in clinical practice and treatment trials: a position paper from the Fleischner Society. Lancet Respir Med. 2015 Jun; 3(6):483-96. Hansell DM, Goldin JG, King TE, Lynch DA, Richeldi L, Wells AU. PMID: 25975761.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    17. Validation of test performance characteristics and minimal clinically important difference of the 6-minute walk test in patients with idiopathic pulmonary fibrosis. Respir Med. 2015 Jul; 109(7):914-22. Nathan SD, du Bois RM, Albera C, Bradford WZ, Costabel U, Kartashov A, Noble PW, Sahn SA, Valeyre D, Weycker D, King TE. PMID: 25956020.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCTClinical Trials
    18. A new era in idiopathic pulmonary fibrosis: considerations for future clinical trials. Eur Respir J. 2015 Jul; 46(1):243-9. Collard HR, Bradford WZ, Cottin V, Flaherty KR, King TE, Koch GG, Kolb M, Martinez FJ, Montgomery B, Raghu G, Richeldi L, Rose D, Wells AU, Brown KK. PMID: 25900377.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    19. Association of hospital admission and forced vital capacity endpoints with survival in patients with idiopathic pulmonary fibrosis: analysis of a pooled cohort from three clinical trials. Lancet Respir Med. 2015 May; 3(5):388-96. Durheim MT, Collard HR, Roberts RS, Brown KK, Flaherty KR, King TE, Palmer SM, Raghu G, Snyder LD, Anstrom KJ, Martinez FJ. PMID: 25890798.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    20. Do all patients with idiopathic pulmonary fibrosis warrant a trial of therapeutic intervention? A pro-con perspective. Respirology. 2015 Apr; 20(3):389-94. Moodley Y, Corte T, Richeldi L, King TE. PMID: 25727967.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    21. Analysis of lung function and survival in RECAP: An open-label extension study of pirfenidone in patients with idiopathic pulmonary fibrosis. Sarcoidosis Vasc Diffuse Lung Dis. 2014 Oct 20; 31(3):198-205. Costabel U, Albera C, Bradford WZ, Hormel P, King TE, Noble PW, Sahn SA, Valeyre D, du Bois RM. PMID: 25363219.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCTClinical Trials
    22. Treatments for idiopathic pulmonary fibrosis. N Engl J Med. 2014 08 21; 371(8):783-4. King TE, Noble PW, Bradford WZ. PMID: 25147884.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    23. Smoking-related idiopathic interstitial pneumonia. Eur Respir J. 2014 Sep; 44(3):594-602. Flaherty KR, Fell C, Aubry MC, Brown K, Colby T, Costabel U, Franks TJ, Gross BH, Hansell DM, Kazerooni E, Kim DS, King TE, Kitachi M, Lynch D, Myers J, Nagai S, Nicholson AG, Poletti V, Raghu G, Selman M, Toews G, Travis W, Wells AU, Vassallo R, Martinez FJ. PMID: 25063244.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansPHPublic Health
    24. Idiopathic pulmonary fibrosis: CT and risk of death. Radiology. 2014 Nov; 273(2):570-9. Ley B, Elicker BM, Hartman TE, Ryerson CJ, Vittinghoff E, Ryu JH, Lee JS, Jones KD, Richeldi L, King TE, Collard HR. PMID: 24927326.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    25. Randomized trial of acetylcysteine in idiopathic pulmonary fibrosis. N Engl J Med. 2014 May 29; 370(22):2093-101. Martinez FJ, de Andrade JA, Anstrom KJ, King TE, Raghu G. PMID: 24836309.
      View in: PubMed   Mentions: 88     Fields:    Translation:Humans
    26. A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. N Engl J Med. 2014 May 29; 370(22):2083-92. King TE, Bradford WZ, Castro-Bernardini S, Fagan EA, Glaspole I, Glassberg MK, Gorina E, Hopkins PM, Kardatzke D, Lancaster L, Lederer DJ, Nathan SD, Pereira CA, Sahn SA, Sussman R, Swigris JJ, Noble PW. PMID: 24836312.
      View in: PubMed   Mentions: 508     Fields:    Translation:HumansCTClinical Trials
    27. Comprehensive assessment of the long-term safety of pirfenidone in patients with idiopathic pulmonary fibrosis. Respirology. 2014 Jul; 19(5):740-7. Valeyre D, Albera C, Bradford WZ, Costabel U, King TE, Leff JA, Noble PW, Sahn SA, du Bois RM. PMID: 24836849.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    28. All-cause mortality rate in patients with idiopathic pulmonary fibrosis. Implications for the design and execution of clinical trials. Am J Respir Crit Care Med. 2014 Apr 01; 189(7):825-31. King TE, Albera C, Bradford WZ, Costabel U, du Bois RM, Leff JA, Nathan SD, Sahn SA, Valeyre D, Noble PW. PMID: 24476390.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    29. Predicting survival across chronic interstitial lung disease: the ILD-GAP model. Chest. 2014 Apr; 145(4):723-728. Ryerson CJ, Vittinghoff E, Ley B, Lee JS, Mooney JJ, Jones KD, Elicker BM, Wolters PJ, Koth LL, King TE, Collard HR. PMID: 24114524.
      View in: PubMed   Mentions: 43     Fields:    Translation:Humans
    30. Future directions in idiopathic pulmonary fibrosis research. An NHLBI workshop report. Am J Respir Crit Care Med. 2014 Jan 15; 189(2):214-22. Blackwell TS, Tager AM, Borok Z, Moore BB, Schwartz DA, Anstrom KJ, Bar-Joseph Z, Bitterman P, Blackburn MR, Bradford W, Brown KK, Chapman HA, Collard HR, Cosgrove GP, Deterding R, Doyle R, Flaherty KR, Garcia CK, Hagood JS, Henke CA, Herzog E, Hogaboam CM, Horowitz JC, King TE, Loyd JE, Lawson WE, Marsh CB, Noble PW, Noth I, Sheppard D, Olsson J, Ortiz LA, O'Riordan TG, Oury TD, Raghu G, Roman J, Sime PJ, Sisson TH, Tschumperlin D, Violette SM, Weaver TE, Wells RG, White ES, Kaminski N, Martinez FJ, Wynn TA, Thannickal VJ, Eu JP. PMID: 24160862.
      View in: PubMed   Mentions: 77     Fields:    Translation:HumansAnimalsCells
    31. Rheumatoid arthritis associated interstitial lung disease: a review. Medicina (B Aires). 2014; 74(2):158-65. Assayag D, Lee JS, King TE. PMID: 24736263.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    32. Predictors of mortality in rheumatoid arthritis-related interstitial lung disease. Respirology. 2014 May; 19(4):493-500. Assayag D, Lubin M, Lee JS, King TE, Collard HR, Ryerson CJ. PMID: 24372981.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    33. Assessing exertional dyspnea in patients with idiopathic pulmonary fibrosis. Respir Med. 2014 Jan; 108(1):181-8. Swigris JJ, Streiner DL, Brown KK, Belkin A, Green KE, Wamboldt FS. PMID: 24388667.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    34. 6-Minute walk distance is an independent predictor of mortality in patients with idiopathic pulmonary fibrosis. Eur Respir J. 2014 May; 43(5):1421-9. du Bois RM, Albera C, Bradford WZ, Costabel U, Leff JA, Noble PW, Sahn SA, Valeyre D, Weycker D, King TE. PMID: 24311766.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansCTClinical Trials
    35. Rheumatoid arthritis-associated interstitial lung disease: radiologic identification of usual interstitial pneumonia pattern. Radiology. 2014 Feb; 270(2):583-8. Assayag D, Elicker BM, Urbania TH, Colby TV, Kang BH, Ryu JH, King TE, Collard HR, Kim DS, Lee JS. PMID: 24126367.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    36. An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med. 2013 Sep 15; 188(6):733-48. Travis WD, Costabel U, Hansell DM, King TE, Lynch DA, Nicholson AG, Ryerson CJ, Ryu JH, Selman M, Wells AU, Behr J, Bouros D, Brown KK, Colby TV, Collard HR, Cordeiro CR, Cottin V, Crestani B, Drent M, Dudden RF, Egan J, Flaherty K, Hogaboam C, Inoue Y, Johkoh T, Kim DS, Kitaichi M, Loyd J, Martinez FJ, Myers J, Protzko S, Raghu G, Richeldi L, Sverzellati N, Swigris J, Valeyre D. PMID: 24032382.
      View in: PubMed   Mentions: 446     Fields:    Translation:Humans
    37. Radiographic fibrosis score predicts survival in hypersensitivity pneumonitis. Chest. 2013 Aug; 144(2):586-592. Mooney JJ, Elicker BM, Urbania TH, Agarwal MR, Ryerson CJ, Nguyen MLT, Woodruff PG, Jones KD, Collard HR, King TE, Koth LL. PMID: 23392130.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    38. Suspected acute exacerbation of idiopathic pulmonary fibrosis as an outcome measure in clinical trials. Respir Res. 2013 Jul 13; 14:73. Collard HR, Yow E, Richeldi L, Anstrom KJ, Glazer C. PMID: 23848435.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    39. Clinical features and outcomes in combined pulmonary fibrosis and emphysema in idiopathic pulmonary fibrosis. Chest. 2013 Jul; 144(1):234-240. Ryerson CJ, Hartman T, Elicker BM, Ley B, Lee JS, Abbritti M, Jones KD, King TE, Ryu J, Collard HR. PMID: 23370641.
      View in: PubMed   Mentions: 53     Fields:    Translation:Humans
    40. Anti-acid treatment and disease progression in idiopathic pulmonary fibrosis: an analysis of data from three randomised controlled trials. Lancet Respir Med. 2013 Jul; 1(5):369-76. Lee JS, Collard HR, Anstrom KJ, Martinez FJ, Noth I, Roberts RS, Yow E, Raghu G. PMID: 24429201.
      View in: PubMed   Mentions: 58     Fields:    Translation:Humans
    41. Reply: idiopathic pulmonary fibrosis: perspectives on clinically meaningful primary endpoints in phase 3 clinical trials. Am J Respir Crit Care Med. 2013 Jun 01; 187(11):1272. Raghu G, Collard HR, Anstrom KJ, Flaherty KR, Fleming TR, King TE, Martinez FJ, Brown KK. PMID: 23725623.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    42. Sildenafil preserves exercise capacity in patients with idiopathic pulmonary fibrosis and right-sided ventricular dysfunction. Chest. 2013 Jun; 143(6):1699-1708. Han MK, Bach DS, Hagan PG, Yow E, Flaherty KR, Toews GB, Anstrom KJ, Martinez FJ. PMID: 23732584.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    43. Prevalence and prognosis of unclassifiable interstitial lung disease. Eur Respir J. 2013 Sep; 42(3):750-7. Ryerson CJ, Urbania TH, Richeldi L, Mooney JJ, Lee JS, Jones KD, Elicker BM, Koth LL, King TE, Wolters PJ, Collard HR. PMID: 23222877.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    44. Prevalence and clinical significance of circulating autoantibodies in idiopathic pulmonary fibrosis. Respir Med. 2013 Feb; 107(2):249-55. Lee JS, Kim EJ, Lynch KL, Elicker B, Ryerson CJ, Katsumoto TR, Shum AK, Wolters PJ, Cerri S, Richeldi L, Jones KD, King TE, Collard HR. PMID: 23186614.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    45. Hypersensitivity pneumonitis: insights in diagnosis and pathobiology. Am J Respir Crit Care Med. 2012 Aug 15; 186(4):314-24. Selman M, Pardo A, King TE. PMID: 22679012.
      View in: PubMed   Mentions: 61     Fields:    Translation:HumansCells
    46. Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis. N Engl J Med. 2012 May 24; 366(21):1968-77. Raghu G, Anstrom KJ, King TE, Lasky JA, Martinez FJ. PMID: 22607134.
      View in: PubMed   Mentions: 248     Fields:    Translation:Humans
    47. A multidimensional index and staging system for idiopathic pulmonary fibrosis. Ann Intern Med. 2012 May 15; 156(10):684-91. Ley B, Ryerson CJ, Vittinghoff E, Ryu JH, Tomassetti S, Lee JS, Poletti V, Buccioli M, Elicker BM, Jones KD, King TE, Collard HR. PMID: 22586007.
      View in: PubMed   Mentions: 136     Fields:    Translation:Humans
    48. A placebo-controlled randomized trial of warfarin in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2012 Jul 01; 186(1):88-95. Noth I, Anstrom KJ, Calvert SB, de Andrade J, Flaherty KR, Glazer C, Kaner RJ, Olman MA. PMID: 22561965.
      View in: PubMed   Mentions: 80     Fields:    Translation:Humans
    49. Idiopathic pulmonary fibrosis: clinically meaningful primary endpoints in phase 3 clinical trials. Am J Respir Crit Care Med. 2012 May 15; 185(10):1044-8. Raghu G, Collard HR, Anstrom KJ, Flaherty KR, Fleming TR, King TE, Martinez FJ, Brown KK. PMID: 22505745.
      View in: PubMed   Mentions: 49     Fields:    Translation:Humans
    50. Relative versus absolute change in forced vital capacity in idiopathic pulmonary fibrosis. Thorax. 2012 May; 67(5):407-11. Richeldi L, Ryerson CJ, Lee JS, Wolters PJ, Koth LL, Ley B, Elicker BM, Jones KD, King TE, Ryu JH, Collard HR. PMID: 22426899.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    51. Interstitial lung diseases. Preface. Clin Chest Med. 2012 Mar; 33(1):xiii. King TE, Collard HR, Richeldi L. PMID: 22365255.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    52. Forced vital capacity in patients with idiopathic pulmonary fibrosis: test properties and minimal clinically important difference. Am J Respir Crit Care Med. 2011 Dec 15; 184(12):1382-9. du Bois RM, Weycker D, Albera C, Bradford WZ, Costabel U, Kartashov A, King TE, Lancaster L, Noble PW, Sahn SA, Thomeer M, Valeyre D, Wells AU. PMID: 21940789.
      View in: PubMed   Mentions: 73     Fields:    Translation:Humans
    53. Ascertainment of individual risk of mortality for patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2011 Aug 15; 184(4):459-66. du Bois RM, Weycker D, Albera C, Bradford WZ, Costabel U, Kartashov A, Lancaster L, Noble PW, Raghu G, Sahn SA, Szwarcberg J, Thomeer M, Valeyre D, King TE. PMID: 21616999.
      View in: PubMed   Mentions: 74     Fields:    Translation:Humans
    54. Idiopathic pulmonary fibrosis. Lancet. 2011 Dec 03; 378(9807):1949-61. King TE, Pardo A, Selman M. PMID: 21719092.
      View in: PubMed   Mentions: 417     Fields:    Translation:Humans
    55. Gastroesophageal reflux therapy is associated with longer survival in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2011 Dec 15; 184(12):1390-4. Lee JS, Ryu JH, Elicker BM, Lydell CP, Jones KD, Wolters PJ, King TE, Collard HR. PMID: 21700909.
      View in: PubMed   Mentions: 75     Fields:    Translation:Humans
    56. Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials. Lancet. 2011 May 21; 377(9779):1760-9. Noble PW, Albera C, Bradford WZ, Costabel U, Glassberg MK, Kardatzke D, King TE, Lancaster L, Sahn SA, Szwarcberg J, Valeyre D, du Bois RM. PMID: 21571362.
      View in: PubMed   Mentions: 306     Fields:    Translation:Humans
    57. BUILD-3: a randomized, controlled trial of bosentan in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2011 Jul 01; 184(1):92-9. King TE, Brown KK, Raghu G, du Bois RM, Lynch DA, Martinez F, Valeyre D, Leconte I, Morganti A, Roux S, Behr J. PMID: 21474646.
      View in: PubMed   Mentions: 90     Fields:    Translation:Humans
    58. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011 Mar 15; 183(6):788-824. Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, Colby TV, Cordier JF, Flaherty KR, Lasky JA, Lynch DA, Ryu JH, Swigris JJ, Wells AU, Ancochea J, Bouros D, Carvalho C, Costabel U, Ebina M, Hansell DM, Johkoh T, Kim DS, King TE, Kondoh Y, Myers J, Müller NL, Nicholson AG, Richeldi L, Selman M, Dudden RF, Griss BS, Protzko SL, Schünemann HJ. PMID: 21471066.
      View in: PubMed   Mentions: 1256     Fields:    Translation:Humans
    59. Smoking and subclinical interstitial lung disease. N Engl J Med. 2011 Mar 10; 364(10):968-70. King TE. PMID: 21388315.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    60. Six-minute-walk test in idiopathic pulmonary fibrosis: test validation and minimal clinically important difference. Am J Respir Crit Care Med. 2011 May 01; 183(9):1231-7. du Bois RM, Weycker D, Albera C, Bradford WZ, Costabel U, Kartashov A, Lancaster L, Noble PW, Sahn SA, Szwarcberg J, Thomeer M, Valeyre D, King TE. PMID: 21131468.
      View in: PubMed   Mentions: 66     Fields:    Translation:HumansCTClinical Trials
    61. Clinical course and prediction of survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2011 Feb 15; 183(4):431-40. Ley B, Collard HR, King TE. PMID: 20935110.
      View in: PubMed   Mentions: 262     Fields:    Translation:Humans
    62. Workshop on idiopathic pulmonary fibrosis in older adults. Chest. 2010 Sep; 138(3):693-703. Castriotta RJ, Eldadah BA, Foster WM, Halter JB, Hazzard WR, Kiley JP, King TE, Horne FM, Nayfield SG, Reynolds HY, Schmader KE, Toews GB, High KP. PMID: 20822991.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    63. Low prevalence of chronic beryllium disease among workers at a nuclear weapons research and development facility. J Occup Environ Med. 2010 Jun; 52(6):647-52. Arjomandi M, Seward J, Gotway MB, Nishimura S, Fulton GP, Thundiyil J, King TE, Harber P, Balmes JR. PMID: 20523233.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    64. Plasma biomarker profiles in acute exacerbation of idiopathic pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol. 2010 Jul; 299(1):L3-7. Collard HR, Calfee CS, Wolters PJ, Song JW, Hong SB, Brady S, Ishizaka A, Jones KD, King TE, Matthay MA, Kim DS. PMID: 20418386.
      View in: PubMed   Mentions: 48     Fields:    Translation:Humans
    65. Does chronic microaspiration cause idiopathic pulmonary fibrosis? Am J Med. 2010 Apr; 123(4):304-11. Lee JS, Collard HR, Raghu G, Sweet MP, Hays SR, Campos GM, Golden JA, King TE. PMID: 20362747.
      View in: PubMed   Mentions: 42     Fields:    Translation:HumansAnimals
    66. Undifferentiated connective tissue disease-associated interstitial lung disease: changes in lung function. Lung. 2010 Apr; 188(2):143-9. Kinder BW, Shariat C, Collard HR, Koth LL, Wolters PJ, Golden JA, Panos RJ, King TE. PMID: 20069430.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    67. Clinical decisions. American Board of Internal Medicine maintenance of certification program. N Engl J Med. 2010 Mar 11; 362(10):948-52. Levinson W, King TE, Goldman L, Goroll AH, Kessler B. PMID: 20220192.
      View in: PubMed   Mentions: 10     Fields:    
    68. The 6 minute walk in idiopathic pulmonary fibrosis: longitudinal changes and minimum important difference. Thorax. 2010 Feb; 65(2):173-7. Swigris JJ, Wamboldt FS, Behr J, du Bois RM, King TE, Raghu G, Brown KK. PMID: 19996335.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    69. Rheumatoid arthritis-associated interstitial lung disease: the relevance of histopathologic and radiographic pattern. Chest. 2009 Nov; 136(5):1397-1405. Kim EJ, Collard HR, King TE. PMID: 19892679.
      View in: PubMed   Mentions: 56     Fields:    Translation:Humans
    70. The SF-36 and SGRQ: validity and first look at minimum important differences in IPF. Respir Med. 2010 Feb; 104(2):296-304. Swigris JJ, Brown KK, Behr J, du Bois RM, King TE, Raghu G, Wamboldt FS. PMID: 19815403.
      View in: PubMed   Mentions: 54     Fields:    Translation:Humans
    71. Multisociety task force recommendations of competencies in Pulmonary and Critical Care Medicine. Am J Respir Crit Care Med. 2009 Aug 15; 180(4):290-5. Buckley JD, Addrizzo-Harris DJ, Clay AS, Curtis JR, Kotloff RM, Lorin SM, Murin S, Sessler CN, Rogers PL, Rosen MJ, Spevetz A, King TE, Malhotra A, Parsons PE. PMID: 19661252.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    72. Effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): a multicentre, randomised, placebo-controlled trial. Lancet. 2009 Jul 18; 374(9685):222-8. King TE, Albera C, Bradford WZ, Costabel U, Hormel P, Lancaster L, Noble PW, Sahn SA, Szwarcberg J, Thomeer M, Valeyre D, du Bois RM. PMID: 19570573.
      View in: PubMed   Mentions: 104     Fields:    Translation:Humans
    73. Serum surfactant protein-A is a strong predictor of early mortality in idiopathic pulmonary fibrosis. Chest. 2009 Jun; 135(6):1557-1563. Kinder BW, Brown KK, McCormack FX, Ix JH, Kervitsky A, Schwarz MI, King TE. PMID: 19255294.
      View in: PubMed   Mentions: 53     Fields:    Translation:Humans
    74. Bosentan for idiopathic pulmonary fibrosis. Curr Opin Investig Drugs. 2008 Nov; 9(11):1171-9. King TE. PMID: 18951296.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimals
    75. Prognostic significance of bronchoalveolar lavage cellular analysis in scleroderma lung disease. Am J Respir Crit Care Med. 2008 Jun 01; 177(11):1292-3; author reply 1293. Kinder BW, King TE. PMID: 18487622.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    76. Idiopathic nonspecific interstitial pneumonia: report of an American Thoracic Society project. Am J Respir Crit Care Med. 2008 Jun 15; 177(12):1338-47. Travis WD, Hunninghake G, King TE, Lynch DA, Colby TV, Galvin JR, Brown KK, Chung MP, Cordier JF, du Bois RM, Flaherty KR, Franks TJ, Hansell DM, Hartman TE, Kazerooni EA, Kim DS, Kitaichi M, Koyama T, Martinez FJ, Nagai S, Midthun DE, Müller NL, Nicholson AG, Raghu G, Selman M, Wells A. PMID: 18388353.
      View in: PubMed   Mentions: 72     Fields:    Translation:Humans
    77. Baseline BAL neutrophilia predicts early mortality in idiopathic pulmonary fibrosis. Chest. 2008 Jan; 133(1):226-32. Kinder BW, Brown KK, Schwarz MI, Ix JH, Kervitsky A, King TE. PMID: 18071016.
      View in: PubMed   Mentions: 38     Fields:    Translation:HumansCells
    78. Challenges in pulmonary fibrosis x 5: the NSIP/UIP debate. Thorax. 2007 Nov; 62(11):1008-12. du Bois R, King TE. PMID: 17965079.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    79. BUILD-1: a randomized placebo-controlled trial of bosentan in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2008 Jan 01; 177(1):75-81. King TE, Behr J, Brown KK, du Bois RM, Lancaster L, de Andrade JA, Stähler G, Leconte I, Roux S, Raghu G. PMID: 17901413.
      View in: PubMed   Mentions: 101     Fields:    Translation:Humans
    80. Use of mycophenolate mofetil to treat scleroderma-associated interstitial lung disease. Respir Med. 2008 Jan; 102(1):150-5. Zamora AC, Wolters PJ, Collard HR, Connolly MK, Elicker BM, Webb WR, King TE, Golden JA. PMID: 17822892.
      View in: PubMed   Mentions: 34     Fields:    Translation:Humans
    81. Clinical and genetic risk factors for pneumonia in systemic lupus erythematosus. Arthritis Rheum. 2007 Aug; 56(8):2679-86. Kinder BW, Freemer MM, King TE, Lum RF, Nititham J, Taylor K, Edberg JC, Bridges SL, Criswell LA. PMID: 17665457.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    82. Acute exacerbations of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2007 Oct 01; 176(7):636-43. Collard HR, Moore BB, Flaherty KR, Brown KK, Kaner RJ, King TE, Lasky JA, Loyd JE, Noth I, Olman MA, Raghu G, Roman J, Ryu JH, Zisman DA, Hunninghake GW, Colby TV, Egan JJ, Hansell DM, Johkoh T, Kaminski N, Kim DS, Kondoh Y, Lynch DA, Müller-Quernheim J, Myers JL, Nicholson AG, Selman M, Toews GB, Wells AU, Martinez FJ. PMID: 17585107.
      View in: PubMed   Mentions: 227     Fields:    Translation:Humans
    83. Idiopathic nonspecific interstitial pneumonia: lung manifestation of undifferentiated connective tissue disease? Am J Respir Crit Care Med. 2007 Oct 01; 176(7):691-7. Kinder BW, Collard HR, Koth L, Daikh DI, Wolters PJ, Elicker B, Jones KD, King TE. PMID: 17556720.
      View in: PubMed   Mentions: 59     Fields:    Translation:Humans
    84. Challenges in pulmonary fibrosis. 1: Use of high resolution CT scanning of the lung for the evaluation of patients with idiopathic interstitial pneumonias. Thorax. 2007 Jun; 62(6):546-53. Gotway MB, Freemer MM, King TE. PMID: 17536033.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    85. Accelerated variant of idiopathic pulmonary fibrosis: clinical behavior and gene expression pattern. PLoS One. 2007 May 30; 2(5):e482. Selman M, Carrillo G, Estrada A, Mejia M, Becerril C, Cisneros J, Gaxiola M, Pérez-Padilla R, Navarro C, Richards T, Dauber J, King TE, Pardo A, Kaminski N. PMID: 17534432.
      View in: PubMed   Mentions: 82     Fields:    Translation:HumansCells
    86. Current diagnosis and management of idiopathic pulmonary fibrosis: a survey of academic physicians. Respir Med. 2007 Sep; 101(9):2011-6. Collard HR, Loyd JE, King TE, Lancaster LH. PMID: 17509853.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansPHPublic Health
    87. Respiratory bronchiolitis-interstitial lung disease: long-term outcome. Chest. 2007 Mar; 131(3):664-671. Portnoy J, Veraldi KL, Schwarz MI, Cool CD, Curran-Everett D, Cherniack RM, King TE, Brown KK. PMID: 17356078.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    88. Clinical problem-solving. Anchors away. N Engl J Med. 2007 Feb 01; 356(5):504-9. Calfee CS, Shah SJ, Wolters PJ, Saint S, King TE. PMID: 17267911.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    89. Idiopathic interstitial pneumonia: do community and academic physicians agree on diagnosis? Am J Respir Crit Care Med. 2007 May 15; 175(10):1054-60. Flaherty KR, Andrei AC, King TE, Raghu G, Colby TV, Wells A, Bassily N, Brown K, du Bois R, Flint A, Gay SE, Gross BH, Kazerooni EA, Knapp R, Louvar E, Lynch D, Nicholson AG, Quick J, Thannickal VJ, Travis WD, Vyskocil J, Wadenstorer FA, Wilt J, Toews GB, Murray S, Martinez FJ. PMID: 17255566.
      View in: PubMed   Mentions: 36     Fields:    Translation:Humans
    90. Anticoagulant therapy and idiopathic pulmonary fibrosis. Chest. 2006 Jul; 130(1):302-3. Kinder BW, Collard HR, King TE. PMID: 16840421.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    91. Current perspectives on the treatment of idiopathic pulmonary fibrosis. Proc Am Thorac Soc. 2006 Jun; 3(4):330-8. Walter N, Collard HR, King TE. PMID: 16738197.
      View in: PubMed   Mentions: 45     Fields:    Translation:Humans
    92. Classification and natural history of the idiopathic interstitial pneumonias. Proc Am Thorac Soc. 2006 Jun; 3(4):285-92. Kim DS, Collard HR, King TE. PMID: 16738191.
      View in: PubMed   Mentions: 96     Fields:    Translation:Humans
    93. Bronchoalveolar lavage fluid D dimer levels are higher and more prevalent in black patients with pulmonary sarcoidosis. Respiration. 2007; 74(3):297-303. Perez RL, Kimani AP, King TE, Aguayo SM, Roman J. PMID: 16534178.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    94. Achieving diversity in academic internal medicine: recommendations for leaders. Am J Med. 2006 Jan; 119(1):76-81. Wesson DE, King TE, Todd RF, Torres EA, Hellmann DB, Flack JM, Dubose TD, Schuster VL. PMID: 16431199.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    95. COPD: a dust-induced disease? Chest. 2005 Oct; 128(4):3055-64. Girod CE, King TE. PMID: 16236986.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansAnimalsCells
    96. A critical assessment of treatment options for idiopathic pulmonary fibrosis. Sarcoidosis Vasc Diffuse Lung Dis. 2005 Oct; 22(3):167-74. Shah NR, Noble P, Jackson RM, King TE, Nathan SD, Padilla M, Raghu G, Rhodes MB, Schwarz M, Tino G, Dubois RW. PMID: 16315778.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    97. Idiopathic interstitial pneumonias: CT features. Radiology. 2005 Jul; 236(1):10-21. Lynch DA, Travis WD, Müller NL, Galvin JR, Hansell DM, Grenier PA, King TE. PMID: 15987960.
      View in: PubMed   Mentions: 49     Fields:    Translation:Humans
    98. The clinical course of patients with idiopathic pulmonary fibrosis. Ann Intern Med. 2005 Jun 21; 142(12 Pt 1):963-7. Martinez FJ, Safrin S, Weycker D, Starko KM, Bradford WZ, King TE, Flaherty KR, Schwartz DA, Noble PW, Raghu G, Brown KK. PMID: 15968010.
      View in: PubMed   Mentions: 146     Fields:    Translation:HumansCTClinical Trials
    99. High-resolution computed tomography in idiopathic pulmonary fibrosis: diagnosis and prognosis. Am J Respir Crit Care Med. 2005 Aug 15; 172(4):488-93. Lynch DA, Godwin JD, Safrin S, Starko KM, Hormel P, Brown KK, Raghu G, King TE, Bradford WZ, Schwartz DA, Richard Webb W. PMID: 15894598.
      View in: PubMed   Mentions: 82     Fields:    Translation:HumansCTClinical Trials
    100. Clinical advances in the diagnosis and therapy of the interstitial lung diseases. Am J Respir Crit Care Med. 2005 Aug 01; 172(3):268-79. King TE. PMID: 15879420.
      View in: PubMed   Mentions: 55     Fields:    Translation:Humans
    101. Analyses of efficacy end points in a controlled trial of interferon-gamma1b for idiopathic pulmonary fibrosis. Chest. 2005 Jan; 127(1):171-7. King TE, Safrin S, Starko KM, Brown KK, Noble PW, Raghu G, Schwartz DA. PMID: 15653980.
      View in: PubMed   Mentions: 37     Fields:    Translation:Humans
    102. Inequality in health care: unjust, inhumane, and unattended! Ann Intern Med. 2004 Nov 16; 141(10):815-7. King TE, Wheeler MB. PMID: 15545683.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    103. Idiopathic interstitial pneumonia: what is the effect of a multidisciplinary approach to diagnosis? Am J Respir Crit Care Med. 2004 Oct 15; 170(8):904-10. Flaherty KR, King TE, Raghu G, Lynch JP, Colby TV, Travis WD, Gross BH, Kazerooni EA, Toews GB, Long Q, Murray S, Lama VN, Gay SE, Martinez FJ. PMID: 15256390.
      View in: PubMed   Mentions: 81     Fields:    Translation:Humans
    104. Combined corticosteroid and cyclophosphamide therapy does not alter survival in idiopathic pulmonary fibrosis. Chest. 2004 Jun; 125(6):2169-74. Collard HR, Ryu JH, Douglas WW, Schwarz MI, Curran-Everett D, King TE, Brown KK. PMID: 15189938.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    105. The effect of pulmonary fibrosis on survival in patients with hypersensitivity pneumonitis. Am J Med. 2004 May 15; 116(10):662-8. Vourlekis JS, Schwarz MI, Cherniack RM, Curran-Everett D, Cool CD, Tuder RM, King TE, Brown KK. PMID: 15121492.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    106. The case for diversity in academic internal medicine. Am J Med. 2004 Feb 15; 116(4):284-9. King TE, Dickinson TA, DuBose TD, Flack JM, Hellmann DB, Pamies RJ, Todd RF, Torres EA, Wesson DE. PMID: 14969662.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    107. A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis. N Engl J Med. 2004 Jan 08; 350(2):125-33. Raghu G, Brown KK, Bradford WZ, Starko K, Noble PW, Schwartz DA, King TE. PMID: 14711911.
      View in: PubMed   Mentions: 118     Fields:    Translation:HumansCTClinical Trials
    108. Idiopathic interstitial pneumonias: progress in classification, diagnosis, pathogenesis and management. Trans Am Clin Climatol Assoc. 2004; 115:43-76; discussion 76-8. King TE. PMID: 17060957.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    109. Miscellaneous causes of bronchiolitis: inhalational, infectious, drug-induced, and idiopathic. Semin Respir Crit Care Med. 2003 Oct; 24(5):567-76. King TE. PMID: 16088573.
      View in: PubMed   Mentions: 2     Fields:    
    110. Radiologic findings are strongly associated with a pathologic diagnosis of usual interstitial pneumonia. Chest. 2003 Oct; 124(4):1215-23. Hunninghake GW, Lynch DA, Galvin JR, Gross BH, Müller N, Schwartz DA, King TE, Lynch JP, Hegele R, Waldron J, Colby TV, Hogg JC. PMID: 14555549.
      View in: PubMed   Mentions: 49     Fields:    Translation:Humans
    111. Sarcoidosis following HIV infection: evidence for CD4+ lymphocyte dependence. Chest. 2003 Sep; 124(3):929-35. Morris DG, Jasmer RM, Huang L, Gotway MB, Nishimura S, King TE. PMID: 12970019.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    112. Changes in clinical and physiologic variables predict survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2003 Sep 01; 168(5):538-42. Collard HR, King TE, Bartelson BB, Vourlekis JS, Schwarz MI, Brown KK. PMID: 12773325.
      View in: PubMed   Mentions: 134     Fields:    Translation:Humans
    113. Demystifying idiopathic interstitial pneumonia. Arch Intern Med. 2003 Jan 13; 163(1):17-29. Collard HR, King TE. PMID: 12523913.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    114. Basic fibroblast growth factor and its receptors in idiopathic pulmonary fibrosis and lymphangioleiomyomatosis. Am J Respir Crit Care Med. 2002 Sep 01; 166(5):765-73. Inoue Y, King TE, Barker E, Daniloff E, Newman LS. PMID: 12204879.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    115. Future research directions in idiopathic pulmonary fibrosis: summary of a National Heart, Lung, and Blood Institute working group. Am J Respir Crit Care Med. 2002 Jul 15; 166(2):236-46. Crystal RG, Bitterman PB, Mossman B, Schwarz MI, Sheppard D, Almasy L, Chapman HA, Friedman SL, King TE, Leinwand LA, Liotta L, Martin GR, Schwartz DA, Schultz GS, Wagner CR, Musson RA. PMID: 12119236.
      View in: PubMed   Mentions: 52     Fields:    Translation:Humans
    116. Nonspecific interstitial pneumonia and systemic sclerosis. Am J Respir Crit Care Med. 2002 Jun 15; 165(12):1578-9. King TE. PMID: 12070054.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    117. Racial disparities in clinical trials. N Engl J Med. 2002 May 02; 346(18):1400-2. King TE. PMID: 11986416.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    118. Nonspecific interstitial pneumonitis as the sole histologic expression of hypersensitivity pneumonitis. Am J Med. 2002 Apr 15; 112(6):490-3. Vourlekis JS, Schwarz MI, Cool CD, Tuder RM, King TE, Brown KK. PMID: 11959061.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    119. Respiratory bronchiolitis-associated interstitial lung disease: radiologic features with clinical and pathologic correlation. J Comput Assist Tomogr. 2002 Jan-Feb; 26(1):13-20. Park JS, Brown KK, Tuder RM, Hale VA, King TE, Lynch DA. PMID: 11801899.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    Talmadge's Networks
    Concepts (312)
    Derived automatically from this person's publications.
    _
    Co-Authors (41)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _